Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-26-000110

Chief Medical Officer sold 4,007 shares at $37.56 ($150,503)

  • Chief Medical Officer acquired 8,375 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Gheuens Sarah · Chief Medical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-07-01 Exercise or conversion : show line 1 in the form 10b5-1 +8,375 88,652 D
2026-07-01 Sale : show line 2 in the form 10b5-1 −4,007 $37.56 $150,503 84,645 D
Open-market sales · 4,007 sh · avg $37.56 · $150,503

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-07-01 Exercise or conversion : show line 3 in the form 10b5-1 Restricted stock units −8,375 0 D
Loading xslF345X06/wk-form4_1783022592.xml…